Adviti Naik

This study examines immune responses in craft and manual workers after a BNT162b2 booster, showing enhanced Th1 and cytotoxic T cell responses, and durable humoral immunity, with prior infection boosting B cell counts.

This study investigates how tumor LDHC expression affects immune responses in breast cancer, finding that LDHC knockdown enhances T cell activation and reduces immunosuppressive factors and checkpoint molecule expression.

This paper evaluates four cell-penetrating peptides for delivering LDHC siRNA to TNBC cells, finding that two show effective LDHC knockdown and tumor reduction in zebrafish models.